ImmunAbs

Q: What is ImmunAbs's official website?

ImmunAbs's official website is www.immunabs.com

Q: What is ImmunAbs's Revenue?

ImmunAbs's revenue is <$5 Million

Q: What industry does ImmunAbs belong to?

ImmunAbs is in the industry of: Business Services , Research & Development

Q: What technology does ImmunAbs use?

Some of the popular technologies that ImmunAbs uses are: JQuery 2.1.1, Google Workspace, jQuery UI, jQuery

Q: How do I contact ImmunAbs?

ImmunAbs contact info: Phone number: +82 269510584 Website: www.immunabs.com

Q: What does ImmunAbs do?

ImmunAbs was established in 2017 by experts of global standard antibody therapeutics development. Our vision is "Hope for Patients, Dreams for Everyone. Currently, we have several antibody therapeutics in global standard development. Antibody is a protein produced by B cell that plays an important role in humoral immunity. Antibodies can specifical... ly bind to various foreign objects and mediate immune responses. Due to the specificity, high affinity, and ability to mediate various efficacy, antibodies have been developed as therapeutics since 1985. So far, more than 90 antibody therapeutics have been licensed for various indications. Of the top 10 world's best-selling drugs in 2019, seven were antibody therapeutics. Antibody therapeutic development requires various know-hows throughout the process, from screening candidates and manufacturing to characterization, BLA approval, and commercialization. ImmunAbs develops antibody therapeutics for orphan diseases, diabetic retinopathy, and diabetes based on its experience in developing antibody therapeutics that have been globally approved for sales in the U.S. and Europe. Read More

Q: Is ImmunAbs a public company?

ImmunAbs is private company therefore does not currently have an official ticker symbol

Business Services · 11-50 Employees

View Company Info for Free

Overview

Phone Number

+82 269510584

Website

www.immunabs.com

Revenue

<$5 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About ImmunAbs

ImmunAbs was established in 2017 by experts of global standard antibody therapeutics development. Our vision is "Hope for Patients, Dreams for Everyone. Currently, we have several antibody therapeutics in global standard development. Antibody is a protein produced by B cell that plays an important role in humoral immunity. Antibodies can specifically bind to various foreign objects and mediate immune responses. Due to the specificity, high affinity, and ability to mediate various efficacy, antibodies have been developed as therapeutics since 1985. So far, more than 90 antibody therapeutics have been licensed for various indications. Of the top 10 world's best-selling drugs in 2019, seven were antibody therapeutics. Antibody therapeutic development requires various know-hows throughout the process, from screening candidates and manufacturing to characterization, BLA approval, and commercialization. ImmunAbs develops antibody therapeutics for orphan diseases, diabetic retinopathy, and diRead more

Is this data correct?

View contact profiles from ImmunAbs

Popular SearchesImmunAbs IncSIC Code 87,873NAICS Code 54,541Show more

ImmunAbs Org Chart

Dongjo Kim

Chief Executive Officer

Phone

Kisu Kim

Head of Research & Development

Phone

Get the full picture

Is ImmunAbs your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Funding: Get notified immidiatlly once ImmunAbs has new funding data

Earning: See what the market has to say on ImmunAbs recently announced quarterly report

Congratulate Masked Content for being promoted to Masked Content at ImmunAbs

Check out if ImmunAbs is spiking on competitors!

Check if ImmunAbs has recently received funding, and reach out quickly before it becomes old news!

Click to see if ImmunAbs had a recent Job posting/layoffs

ImmunAbs, which may be a good buyer, showed buying intent in Masked Content Topic

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when ImmunAbs launches new products

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 2 more new buyers

View Email Formats for ImmunAbs

Among all Business Services companies

Low Activity

High Activity

Activity Insights

ImmunAbs is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

ImmunAbs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImmunAbs.